MindLeap Health Enters into Fast-Growing Telehealth Market
September 29, 2020
Ryan Allway September 29th, 2020 App, Exclusive, Psychedelics, Top Story The COVID-19 pandemic has led to dramatic changes in healthcare. In addition to mobilizing a vaccine in record time, the pandemic could permanently alter the way that many people seek medical care, shifting from in-person to telehealth. These changes... Read more
Havn Life Sciences Submits Range of Natural Health Products to Health Canada
September 25, 2020
Ryan Allway September 25th, 2020 Psychedelics Havn Life Sciences Inc. (CSE:HAVN)(FSE:5NP) (the “Company” or “Havn Life”), a biotechnology company focused on unlocking human potential using evidence-informed research and developing standardized psychoactive compounds derived from plants and fungi, is pleased to announce it has submitted formulations for its natural health products... Read more
Revive Therapeutics Provides Corporate Update on Its Psychedelics Therapeutics Programs
September 25, 2020
Ryan Allway September 25th, 2020 Psychedelics Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, US: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to provide a corporate update on its psychedelics therapeutics programs specifically... Read more
Mind Cure Adds Alain Roy as a Product Development Specialist
September 24, 2020
Mind Cure makes addition to its teamMoonbeam Functional Mushrooms in final testing stage VANCOUVER , Sept. 24, 2020 /CNW/ – Mind Cure Health Inc. (CSE: MCUR) ( “Mind Cure” or the “Corporation” ) is pleased today to announce the addition Alain Roy to the company. Alain Roy is a product development expert with over 30 years of experience creating and... Read more
Mindleap Health Announces The Launch of The World’s First Telehealth Platform For Psychedelic Integration
September 24, 2020
Ryan Allway September 24th, 2020 Exclusive, Psychedelics, Top News DENVER, Sept. 24, 2020 (GLOBE NEWSWIRE) — Mydecine Innovations Group Inc. (MYCO.CN) (MYCOF) (0NF.F) (“Mydecine” or the “Company”), is pleased to announce that its subsidiary Mindleap Health’s (“Mindleap” ) telehealth platform will be officially available for download from the iOS... Read more
MindMed Submits Application For NASDAQ Up-Listing, Appoints Canaccord Genuity As Financial Advisor
September 21, 2020
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
MagicMed Closes Oversubscribed $1.6M Private Placement to Build Out Its Psybrary™
September 21, 2020
Ryan Allway September 21st, 2020 App, Psychedelics, Top Story The burgeoning psychedelics sector in many ways resembles the cannabis industry of a decade ago. With rising interest in psychedelic medicine, analysts project that the market could grow at a 16.3% compound annual growth rate to $6.85 billion by 2027.... Read more
Ryan Allway September 18th, 2020 Psychedelics Mind Cure Health Inc. (CSE: MCUR) (“Mind Cure” or the “Corporation“) is pleased to announce that it has closed its previously announced initial public offering (the “Offering“) of common shares of the Corporation (the “Shares“) under the Corporation’s final prospectus dated August 27,... Read more
COMPASS Pathways Announces Pricing of Upsized IPO
September 18, 2020
Ryan Allway September 18th, 2020 Psychedelics COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the pricing of its upsized initial public offering in the United States of 7,500,000 American Depositary Shares (“ADSs”) representing... Read more
New Wave Holdings Appoints Daniel Fox as CEO & Diego Gianelli as Director
September 17, 2020
Ryan Allway September 17th, 2020 Psychedelics NEW WAVE HOLDINGS CORP. (the “Company” or “New Wave Holdings“) (CSE: SPOR) (Frankfurt: 0XM2) (OTC: TRMND), an investment issuer focused on emerging sectors including the psychedelic sector, is pleased to announce the appointment of Daniel Fox as Chief Executive Officer (“CEO”) and Diego Gianelli to the Board... Read more
